Improving Patient Representation in Clinical Trials

In Conversation with Dija Atta and Stacy Eckstein

In this interview, Ryan Brown, Regional VP of Sales at H1, was fortunate enough to be able to chat with not one but two of Incyte’s diversity leaders – Dija Atta, Head of Regional Clinical Operations in North America, and Stacy Eckstein, Manager of Global Site ID & Feasibility. Together, they lead a committee whose mission is to improve patient representation in clinical trials as well as knowledge, awareness, and access to tools that support clinical trial diversity.

Listen to the full interview to hear how Incyte is preparing to meet FDA diversity planning requirements, how technology plays a role in their strategy, and how diversity insights are transforming their approach to feasibility and site selection.

"We really sat down and thought about, well, what’s the framework and the way in which we want to approach diversity planning across all of our trials. So we established a roadmap to be able to do that."

The interview covers:

• Developing a strategy to promote diversity & inclusion in clinical trials
• The role of technology and data in clinical trial diversity planning
• Using site and real-world data to inform global feasibility in site selection
• Finding net new HCPs to collaborate with in new locations

Watch the interview:

To find out how H1 can support your organization’s diversity planning, feasibility, and site selection, request a demo.